|
End-of-day quote
New Zealand S.E.
29/10/2026
|
5-day change | 1st Jan Change | ||
| 20.08 NZD | -0.84% |
|
-4.83% | -27.30% |
| 10-27 | Craigs Investment Partners Adjusts EBOS Group's Price Target to NZ$29.42 | MT |
| 10-21 | EBOS Group Limited - Shareholder/Analyst Call |
ETFs positioned on EBOS Group Limited
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
| +6.23% | - | 49 M€ | ||
| +6.15% | - | 1,193 M€ | ||
| +0.94% | - | 51 M€ | ||
| +18.84% | - | 110 M€ | ||
| +9.01% | - | 274 M€ | ||
| -1.57% | 3.8% | 82 M€ | ||
| +10.79% | 1.09% | 249 M€ | ||
| +12.13% | 0.43% | 124 M€ | ||
| +14.56% | 0.42% | 6 M€ | ||
| -17.68% | 0.4% | 94 M€ | ||
| +9.95% | 0.33% | 2 M€ | ||
| -20.44% | 0.32% | 20 M€ | ||
| +16.60% | 0.29% | 353 M€ | ||
| +1.45% | 0.22% | 2 M€ | ||
| +16.44% | 0.14% | 758 M€ | ||
| +18.76% | 0.14% | 567 M€ | ||
| +39.97% | 0.13% | 1,037 M€ | ||
| +10.81% | 0.12% | 81 M€ | ||
| +10.89% | 0.11% | 270 M€ | ||
| +11.13% | 0.11% | 792 M€ | ||
| +19.65% | 0.09% | 160 M€ | ||
| +10.98% | 0.08% | 3,151 M€ | ||
| +7.89% | 0.08% | 13,445 M€ | ||
| +10.57% | 0.07% | 258 M€ | ||
| -.--% | 0.07% | 11 M€ | ||
| +14.85% | 0.07% | 4,105 M€ | ||
| +17.92% | 0.07% | 475 M€ | ||
| +7.67% | 0.06% | 9,264 M€ | ||
| +31.10% | 0.05% | 2,019 M€ | ||
| +13.14% | 0.05% | 679 M€ | ||
| +16.68% | 0.05% | 611 M€ | ||
| +16.73% | 0.05% | 12 M€ | ||
| +21.89% | 0.05% | 63 M€ | ||
| +11.78% | 0.05% | 167 M€ |
Employees
5,364
Sector
Pharmaceuticals
- Stock Market
- Stocks
- EBO Stock
- ETFs EBOS Group Limited
Select your edition
All financial news and data tailored to specific country editions
















